This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...

Centene reported $42.5 billion in premium and service revenue for the quarter. However, adjusted EPS came in at a loss of ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Centene’s stock plummeted Friday morning to reach its lowest level since 2015 after the insurer reported second-quarter earnings well below analyst expectations. Though Centene’s revenue ...

Centene (NYSE:CNC) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ...

What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the ...

Centene Corporation (NYSE:CNC) experienced a challenging Tuesday evening, witnessing a 25% drop in shares during after-hours trading on July 1st. The significant decline in the healthcare giant's ...

J.P. Morgan analyst John Stansel downgraded Centene's stock to neutral from overweight, as it remains unclear how the company will be able to correct its healthcare pricing in 2026, ...